Osmoprotectants in Hybrid Liposome/HPMC Systems as Potential Glaucoma Treatment

Polymers - Switzerland
doi 10.3390/polym11060929
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

Liposome Delivery Systems for the Treatment of Alzheimer’s Disease

International Journal of Nanomedicine
Organic ChemistryBiophysicsBiomaterialsPharmaceutical ScienceMedicineBioengineeringDrug DiscoveryNanoscienceNanotechnology
2018English

Evaluation of Liposome-Encapsulated Hemoglobin/Lr16 Formulation as a Potential Blood Substitute.

1990English

Efficacy of Osmoprotectants on Prevention and Treatment of Murine Dry Eye

Investigative Ophthalmology and Visual Science
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2013English

Liposome-Incorporated Ciprofloxacin in Treatment of Murine Salmonellosis.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1993English

Selective Laser Trabeculoplasty as Primary Treatment for Open-Angle Glaucoma

Archives of Ophthalmology
2003English

Arah Dan Perkembangan Liposome Drugs Delivery Systems

Majalah Ilmu Kefarmasian
2004English

EX-PRESS and Ahmed Glaucoma Valve in Treatment of Refractory Glaucoma

Acta Ophthalmologica
MedicineOphthalmology
2015English

Organic Nanoparticles as Drug Delivery Systems and Their Potential Role in the Treatment of Chronic Myeloid Leukemia

Technology in Cancer Research and Treatment
MedicineCancer ResearchOncology
2019English

Quantitative Systems Pharmacology Model for Alzheimer's Disease Indicates Targeting Sphingolipid Dysregulation as Potential Treatment Option

CPT: Pharmacometrics and Systems Pharmacology
ModelingSimulationCardiovascular MedicinePharmacologyCardiology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy